600223 Lushang Freda Pharmaceutical
- 7.30
- -0.06-0.82%
Lushang Freda Pharmaceutical News
Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the election of employee supervisor.
Lushang Freda Pharmaceutical Co., Ltd.'s 2023 Annual Shareholders' Meeting Materials
Notice on the convening of the 2023 annual shareholder meeting of Lushang Freda Pharmaceutical Co., Ltd.
Summary Report of Minsheng Securities Co., Ltd. on the continuous listing of Lushang Life Service Co., Ltd., a subsidiary of Lushang Freda Pharmaceutical Co., Ltd.
2023 Internal Control Evaluation Report of Lushang Freda Pharmaceutical Co., Ltd.
Summary Report on the Performance of the 2023 Audit Committee of Lushang Freda Pharmaceutical Co., Ltd.
Report of the Audit Committee of the Board of Directors of Lushang Freda Pharmaceutical Co., Ltd. on the evaluation of the accounting firm's performance in 2023 and the performance of supervisory duties
Special Report of the Board of Directors of Lushang Freda Pharmaceutical Co., Ltd. on the independence of independent directors in 2023
Risk management plan for Lushang Freda Pharmaceutical Co., Ltd. to carry out financial business at Shandong Commercial Group Finance Co., Ltd.
Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the transfer of 100% shares and related transactions of Shandong Huibangda Decoration Engineering Co., Ltd. by its holding subsidiary
Announcement of Lushang Freda Pharmaceutical Co., Ltd. on authorizing the Deputy General Manager to act as General Manager
Announcement of Resolutions of the 2023 Second Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Legal Opinion of Guohao Law Firm (Jinan) on the 2023 Second Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Announcement of Lushang Freda Pharmaceutical Co., Ltd. on amending the “Articles of Association”
Notice of Lushang Freda Pharmaceutical Co., Ltd. on holding the 2nd Extraordinary General Meeting of Shareholders in 2023
Meeting materials of the 2023 Second Extraordinary General Meeting of Shareholders of Lushang Freda Pharmaceutical Co., Ltd.
Independent opinions of the independent director of Lushang Freida Pharmaceutical Co., Ltd. on the change of company directors and the appointment of senior managers
Explanation of the independent director of Lushang Freida Pharmaceutical Co., Ltd. on prior approval of company-related transactions
Announcement of Lushang Freida Pharmaceutical Co., Ltd. on the company\'s asset impairment preparations for the semi-annual calculation of 2023
Lushang Furuida Pharmaceutical Co., Ltd. Stock Abbreviation Change Implementation Notice
Analysis
Price Target
No Data
